Bioxcel Therapeutics Stock Forecast

Sell candidate since Jul 06, 2026 Loss -6.36%

The BioXcel Therapeutics Inc. stock price gained 16.75% on the last trading day (Tuesday, 14th Jul 2026), rising from $0.88 to $1.03. During the last trading day the stock fluctuated 32.95% from a day low at $0.88 to a day high of $1.17. The price has been going up and down for this period, and there has been a -26.43% loss for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 3 million more shares were traded than the day before. In total, 5 million shares were bought and sold for approximately $4.93 million.

The stock is moving within a very wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect BioXcel Therapeutics Inc. stock with a 90% probability to be traded between $0.786 and $1.38 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

BTAI Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, July 08, 2026, and so far it has risen 28.40%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The BioXcel Therapeutics Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $1.16. On a fall, the stock will find some support from the short-term average at $0.93. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for BioXcel Therapeutics Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.88 and $0.84. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, BioXcel Therapeutics Inc. finds support just below today's level at $0.88. If this is broken, then the next support from accumulated volume will be at $0.84 and $0.80.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.290 between high and low, or 32.95%. For the last week, the stock has had daily average volatility of 21.53%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (BTAI) For The Upcoming Trading Day Of Wednesday 15th

For the upcoming trading day on Wednesday, 15th we expect BioXcel Therapeutics Inc. to open at $1.03, and during the day (based on 14 day Average True Range), to move between $0.97 and $1.09, which gives a possible trading interval of +/-$0.120 (+/-12.41%) up or down from last closing price. If BioXcel Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 12.41% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $1.04 (0.97%) than the support at $0.88 (14.35%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is BioXcel Therapeutics Inc. stock A Buy?

BioXcel Therapeutics Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -1.024 Sell Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on July 15, 2026 - $1.03 ( 0.324%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk